Clinical Trial Update: Interleukin-12 in Treating Patients With Metastatic or Recurrent Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating interleukin-12 for metastatic or recurrent breast cancer has completed enrollment. The update summarizes the trial results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Interleukin-12 (interleukin-12)

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED